CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO
Scribe Therapeutics’ IPO will support a pipeline led by a genetic medicine that represses expression of its target gene without making permanent changes. Common chronic cardiometabolic conditions are Scribe’s initial focus as the biotech works to bring genetic medicines beyond rare diseases.
Healthcare Investors Are Rewriting the ROI Playbook from Cost-Cutting to Cash Flow
Unlike past healthcare tech waves sold on cost savings, AI is proving it can generate new revenue — with returns as high as 100x, according to a panel of investors at MedCity News' Bullseye event.
Who Broke the Healthcare System?
SCAN Health Plan CEO Sachin Jain and Ascendiun CEO Paul Markovich argued that healthcare leaders share responsibility for the industry's shortcomings and called for greater accountability and systemic reform.
Rethinking How Hospitals Measure Behavioral Health Success
Hospitals that see improved long-term results in behavioral health patients will be those that prioritize metrics aligned with their care pathways.
Four Ways Health Systems Should Plan for the Next Wave of Breakthrough Therapies
Groundbreaking new therapies have exciting potential to treat and cure diseases while minimizing burden on patients; however, they create major clinical, operational and financial implications that must be planned for years in advance.